Omega Healthcare Investors (NYSE:OHI) Issues Quarterly Earnings Results

Key Points

• Omega Healthcare Investors beat quarterly expectations: The healthcare REIT reported $0.83 in EPS versus the $0.51 consensus estimate and revenue of $328.25 million, up 16.2% year over year. It updated fiscal 2026 EPS guidance to $3.22–$3.26.
• The dividend increased: Omega raised its quarterly dividend from $0.67 to $0.68 per share, equating to an annualized $2.72 payout and a 5.3% yield.
• Market sentiment remains cautious: Shares slipped 0.6% to $51.32, while analysts’ consensus rating remained “Hold” with an average price target of $48.50; institutional investors own 65.25% of the stock.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) released its earnings results on Wednesday. The real estate investment trust reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.51 by $0.32, Zacks reports. The company had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The company's revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. Omega Healthcare Investors updated its FY 2026 guidance to 3.220-3.260 EPS.

Omega Healthcare Investors Trading Down 0.6%

Shares of OHI stock traded down $0.32 on Wednesday, reaching $51.32. The company had a trading volume of 2,450,546 shares, compared to its average volume of 1,690,623. The stock has a market cap of $15.28 billion, a PE ratio of 24.79, a PEG ratio of 2.20 and a beta of 0.58. The company has a 50-day moving average of $47.65 and a 200-day moving average of $46.59. The company has a current ratio of 5.32, a quick ratio of 5.32 and a debt-to-equity ratio of 0.81. Omega Healthcare Investors has a 12 month low of $38.59 and a 12 month high of $52.07.

Omega Healthcare Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, August 3rd will be paid a $0.68 dividend. This is a boost from Omega Healthcare Investors's previous quarterly dividend of $0.67. The ex-dividend date of this dividend is Monday, August 3rd. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.3%. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 129.47%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Royal Bank of Canada raised its holdings in Omega Healthcare Investors by 29.4% in the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust's stock worth $5,496,000 after purchasing an additional 32,798 shares during the period. Focus Partners Wealth grew its holdings in shares of Omega Healthcare Investors by 3.1% in the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust's stock valued at $756,000 after buying an additional 597 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at $257,000. Guggenheim Capital LLC increased its position in shares of Omega Healthcare Investors by 1.0% in the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust's stock valued at $1,077,000 after buying an additional 280 shares in the last quarter. Finally, First Trust Advisors LP raised its stake in Omega Healthcare Investors by 32.8% during the 2nd quarter. First Trust Advisors LP now owns 193,099 shares of the real estate investment trust's stock worth $7,077,000 after buying an additional 47,649 shares during the period. Institutional investors and hedge funds own 65.25% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on OHI. Barclays began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, July 7th. They set an "underweight" rating and a $51.00 price target for the company. Raymond James Financial started coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They issued an "outperform" rating and a $50.00 price objective on the stock. Weiss Ratings raised shares of Omega Healthcare Investors from a "buy (b)" rating to a "buy (b+)" rating in a report on Tuesday, June 30th. UBS Group set a $47.00 target price on shares of Omega Healthcare Investors in a research report on Thursday, June 18th. Finally, Bank of America reissued an "underperform" rating and issued a $46.00 price target (down from $52.00) on shares of Omega Healthcare Investors in a research note on Tuesday, April 14th. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Omega Healthcare Investors presently has a consensus rating of "Hold" and a consensus price target of $48.50.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.